Streptococcal Pharyngitis Therapy
- 1 November 1979
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Diseases of Children
- Vol. 133 (11) , 1146-1148
- https://doi.org/10.1001/archpedi.1979.02130110054008
Abstract
• The recommended dosage of erythromycin, without regard to the formulation prescribed, for children with streptococcal pharyngitis is 30 to 40 mg/kg/day. We previously reported an acceptable streptococcal eradication rate among patients with pharyngitis treated with erythromycin estolate, 20 mg/kg/day. In this study, an extension of the earlier one, the efficacy of this same dosage of erythromycin estolate was compared with a 40 mg/kg/day dosage of erythromycin ethylsuccinate. Streptococcal eradication rates were nearly identical in the two groups of patients. The efficacy of erythromycin estolate at a dosage lower than that recommended for children is most likely explained on pharmacologic grounds: better absorption and higher levels in serum and tissue than those achieved with other erythromycin formulations. It seems rational to calculate required dosages of erythromycin on the basis of the formulation being administered. (Am J Dis Child 133:1146-1148, 1979)This publication has 10 references indexed in Scilit:
- Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensionsThe Journal of Pediatrics, 1976
- Erythromycin Therapy for Streptococcal PharyngitisArchives of Pediatrics & Adolescent Medicine, 1976
- Compliance Dose-Response Relationships in Streptococcal PharyngitisArchives of Pediatrics & Adolescent Medicine, 1972
- STREPTOCOCCAL ANTI-DESOXYRIBONUCLEASE B - MICROTECHNIQUE DETERMINATION1968
- B-Hemolytic Streptococcal IllnessAmerican Journal of Diseases of Children, 1966
- ANTIBIOTIC SUSCEPTIBILITY TESTING BY A STANDARDIZED SINGLE DISK METHOD1966
- COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATEThe Lancet Healthy Longevity, 1964
- The Use of Bacitracin for Identifying Group A Haemolytic StreptococciJournal of Clinical Pathology, 1953